固定注射速率与固定注射时长在单期增强腹部多排CT中对血管强化的影响
99例非创伤性急腹症患者行单期增强腹部多排CT,对比固定速率(2 cc/s,A组)与固定时长(55 s,B组)注射1.7 cc/Kg非离子碘对比剂(370 mgI/mL)对血管强化的影响。高体重亚组中B组腹主动脉和门静脉的SNR与CNR显著更高(P < .01),低体重亚组虽B组注射速率显著更低(1.6 ± 0.2 cc/s,P < .01)但差异无统计学意义;结论认为固定注射时长整体血管强化更优。
要点
- 高体重(81–100 kg)患者采用固定注射时长55 s较固定速率2 cc/s可获得更高的腹主动脉和门静脉SNR与CNR(P < .01)。
- 低体重(40–60 kg)患者中固定注射时长组注射速率显著更低(1.6 ± 0.2 cc/s,P < .01),但血管强化差异无统计学意义。
- 中等体重(61–80 kg)亚组中两种注射方案血管强化结果重叠。
核心结论
- 在单期增强腹部多排CT中,固定注射时长(55 s)较固定速率(2 cc/s)整体血管强化更优。
研究设计与样本
- 99例(54男、45女,年龄18–86岁)非创伤性急腹症患者行单期增强腹部多排CT,静脉注射1.7 cc/Kg非离子碘对比剂(370 mgI/mL),分为固定速率组(2 cc/s,A组)和固定注射时长组(55 s,B组),并按总体重分层为40–60 kg(L)、61–80 kg(M)、81–100 kg(H)亚组。
诊断标准与关键数值
- 计算肝脏、腹主动脉和门静脉的信噪比(SNR)与对比噪声比(CNR)。
- 高体重亚组(n = 20)中B组腹主动脉和门静脉的SNR与CNR显著高于A组(P < .01)。
- 低体重亚组(n = 40)中B组注射速率显著更低(1.6 ± 0.2 cc/s,P < .01),但血管强化差异无统计学意义。
- 中等体重亚组(n = 40)中两组血管强化结果重叠。
临床应用与阅片要点
- 单期方案是优化的增强腹部CT协议,结合了血管和内脏强化优势,采用围绕单相对比剂注射定制的扫描延迟。
- 在单期方案中,固定注射时长(55 s)较固定速率(2 cc/s)整体血管强化更优,应视为首选的注射方式。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the effects on vascular enhancement of either a fixed rate (FR) or a fixed injection duration (FID) in single-pass (SP) contrast-enhanced abdominal multi-detector CT (CE-MDCT).
METHODS: Ninety-nine (54 M; 45 F; aged 18-86 years) patients with nontraumatic acute abdomen underwent a SP CE-MDCT after i.v. injection of 1.7 cc/Kg of a nonionic iodinated contrast media (370 mgI/mL) performed with either a FR (2 cc/s; Group A) or a FID (55 s; Group B). In both groups, patients were further stratified according to total body weight (kg) as follows: 40-60 (L); 61-80 (M); 81-100 (H). Signal- (SNR) and contrast-to-noise ratios (CNR) were calculated for the liver and for both abdominal aorta (AA) and main portal vein (MPV). Statistical analysis was performed by Student t- or Chi-square test for continuous and categorical data, respectively, whereas post hoc analysis was performed by the Mann-Whitney test (P < .05).
RESULTS: There were no significant differences in demographic and physical characteristics between Group A (n = 50; 53 ± 20 years; BMI = 23.4 ± 4.4) and Group B (n = 50; 51 ± 17 years; BMI 22.7 ± 4.2). Whereas overlapping findings were observed in the M sub-groups (n = 40), SNR and CNR were significantly higher (P < .01) in Group B for both AA and MPV in the high (H) weight sub-groups (n = 20) while not significant differences were observed in the low (L) weight sub-groups (n = 40) despite a significantly lower injection rate (1.6 ± 0.2 cc/s, P < .01) in Group B.
CONCLUSION: A FID results in an overall better vascular enhancement than a FR in SP CE-MDCT.
ADVANCES IN KNOWLEDGE: Single-pass is an optimized contrast-enhanced abdominal CT protocol combining the benefits of vascular and visceral enhancement and characterized by a customized scan delay tailored around a monophasic contrast injection. In single-pass protocol, a fixed injection duration (55 s) results in an overall better vascular enhancement than a fixed rate (2 cc/s) and should be therefore regarded as the injection modality of choice.
引用
- Camera L, D'Ambrosio V, Pinto L, et al. Fixed rate vs fixed injection duration in single-pass contrast-enhanced abdominal multi-detector CT: effects on vascular enhancement. Br J Radiol. 2025. PMID: 39374549. doi:10.1093/bjr/tqae202
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。